Alert: Major Price Advance (6/17/24)-Lipocine Inc (NASDAQ: LPCN).

out_logo_500#71755.jpg

On 6/17/24, Lipocine Inc (NASDAQ: LPCN) stock enjoyed a major increase of 12.6%, closing at $10.69. Moreover, this advance was accompanied by exceptionally high trading volume at 252% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 42.2% during the last week.

out_mm#71755.jpg

Current PriceTarget Research Rating

LPCN’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.

Lipocine has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Lipocine has a poor Appreciation Score of 20 but a very high Power Rating of 95, with the High Neutral Value Trend Rating the result.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.


*